Clinical Trials

Carcinoma, Hepatocellular

NCT05913570 2023-06-22

MSI-H/dMMR

22 enrolled

Turcot syndrome, Colorectal Neoplasms

NCT01628211 2023-03-24

HIPEC

140 enrolled

Colorectal Neoplasms

NCT05479409 2022-07-29

Neoadjuvant Radiation in Locally Advanced Breast Cancer

Breast Neoplasms

NCT05468177 2022-07-21

CIFOXRC

66 enrolled

Colonic Neoplasms

NCT05351762 2022-07-05

Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC

55 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05424432 2022-06-27

SCALE-2

63 enrolled

Esophageal Neoplasms

NCT05399394 2022-06-01

FOLRT

Pancreatic Neoplasms

NCT05371197 2022-05-12

Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer

26 enrolled

Turcot syndrome, Colorectal Neoplasms

NCT05340231 2022-04-22

An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)

100 enrolled

Colorectal Neoplasms

NCT05113459 2021-11-09

Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018）

40 enrolled

Stomach Neoplasms

NCT04170179 2021-02-23

Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis

25 enrolled

Carcinoma, Hepatocellular

NCT04523402 2020-08-21

Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis

100 enrolled

Cholangiocarcinoma

NCT04506281 2020-08-10

PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

128 enrolled

Cholangiocarcinoma

NCT04411524 2020-06-02

The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

NCT04411537 2020-06-02

The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal Cancer

Locally Advanced Rectal Cancer

NCT04319874 2020-03-30

Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma

80 enrolled

Sarcoma

Osteosarcoma

NCT04294511 2020-03-04

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

75 enrolled

Sarcoma

Osteosarcoma

NCT03957564 2020-01-22

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

40 enrolled

Neoplastic Cells, Circulating, Stomach Neoplasms

NCT02404753 2018-09-28

REALIZATION

102 enrolled

Stomach Neoplasms

NCT02572492 2018-08-17

CARFI

200 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT02779608 2017-01-24

The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites

Stomach Neoplasms

NCT00491816 2017-01-19

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

32 enrolled

Breast Neoplasms, Neoplasms

NCT02934828 2016-10-18

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

230 enrolled

Breast Neoplasms

NCT02591667 2016-04-05

CARCINOSIS

30 enrolled

Colorectal Neoplasms

NCT00077389 2014-06-24

Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma

57 enrolled

Liver Neoplasms, Hepatoblastoma

NCT00717587 2014-01-10

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

20 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00967655 2014-01-10

Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer

54 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT00036985 2013-12-19

Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer

Breast Neoplasms

NCT00036998 2013-11-06

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

Breast Neoplasms

NCT00003261 2013-09-20

Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma

14 enrolled

Lymphoid

Lymphoma

NCT00088816 2013-09-17

S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer

Stomach Neoplasms

NCT00134095 2013-09-17

S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer

70 enrolled

Stomach Neoplasms

NCT00276705 2013-09-17

Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer

47 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00462397 2013-08-26

Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Gynecologic

Uterine Cervical Neoplasms

NCT00533936 2013-08-26

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

160 enrolled

Breast Neoplasms

NCT01926483 2013-08-21

ZTOG-1202

75 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00398385 2013-08-12

Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer

170 enrolled

Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00626509 2013-08-12

Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer

110 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01222676 2013-08-12

Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder

45 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT01463501 2013-05-14

Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer

Esophageal Neoplasms

NCT01641406 2012-07-16

NACprotocol

Breast Carcinoma In Situ, Carcinoma, Lobular, Inflammatory Breast Neoplasms

NCT00830544 2012-07-13

Neoadjuvant

54 enrolled

Breast Neoplasms

NCT00620269 2011-11-07

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

212 enrolled

Thoracic

Lung Neoplasms

NCT00659022 2011-09-12

Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth

Liver Neoplasms, Colorectal Neoplasms

NCT00438737 2011-09-02

Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer

100 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00471484 2011-06-22

Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery

54 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

94 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00994968 2010-10-29

Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer

49 enrolled